Your search returned 8 results.

Results
	1.	[Form of transport of isothiocyanates, stability and cleavability. 3. On therapy with isothiocyanate groups]. [electronic resource] by SCHULTZ, O E GLEIXNER, K Producer: 19981101 In: Archiv der Pharmazie und Berichte der Deutschen Pharmazeutischen Gesellschaft vol. 295/67 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	[Pharmacokinetic studies following oral administration of 3,7-dimethyl-1-(5-oxo-hexyl)xanthine- 14 C (BL 191- 14 C) in rats, dogs and man]. [electronic resource] by Christ, O Gleixner, K Kellner, H M Müller, R Rupp, W Producer: 19730622 In: Arzneimittel-Forschung vol. 22 Availability: No items available. Save to lists Add to cart (remove)
	3.	Treatment responses to cladribine and dasatinib in rapidly progressing aggressive mastocytosis. [electronic resource] by Aichberger, K J Sperr, W R Gleixner, K V Kretschmer, A Valent, P Producer: 20090220 In: European journal of clinical investigation vol. 38 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	The KIT D816V allele burden predicts survival in patients with mastocytosis and correlates with the WHO type of the disease. [electronic resource] by Hoermann, G Gleixner, K V Dinu, G E Kundi, M Greiner, G Wimazal, F Hadzijusufovic, E Mitterbauer, G Mannhalter, C Valent, P Sperr, W R Producer: 20141229 In: Allergy vol. 69 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Targeting of mTOR is associated with decreased growth and decreased VEGF expression in acute myeloid leukaemia cells. [electronic resource] by Böhm, A Aichberger, K J Mayerhofer, M Herrmann, H Florian, S Krauth, M-T Derdak, S Samorapoompichit, P Sonneck, K Vales, A Gleixner, K V Pickl, W F Sperr, W R Valent, P Producer: 20091009 In: European journal of clinical investigation vol. 39 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	The Hsp32 inhibitors SMA-ZnPP and PEG-ZnPP exert major growth-inhibitory effects on D34+/CD38+ and CD34+/CD38- AML progenitor cells. [electronic resource] by Herrmann, H Kneidinger, M Cerny-Reiterer, S Rülicke, T Willmann, M Gleixner, K V Blatt, K Hörmann, G Peter, B Samorapoompichit, P Pickl, W Bharate, G Y Mayerhofer, M Sperr, W R Maeda, H Valent, P Producer: 20120920 In: Current cancer drug targets vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Midostaurin: a magic bullet that blocks mast cell expansion and activation. [electronic resource] by Valent, P Akin, C Hartmann, K George, T I Sotlar, K Peter, B Gleixner, K V Blatt, K Sperr, W R Manley, P W Hermine, O Kluin-Nelemans, H C Arock, M Horny, H-P Reiter, A Gotlib, J Producer: 20180529 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 28 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Targeting of Hsp32 in solid tumors and leukemias: a novel approach to optimize anticancer therapy. [electronic resource] by Gleixner, K V Mayerhofer, M Vales, A Gruze, A Hörmann, G Cerny-Reiterer, S Lackner, E Hadzijusufovic, E Herrmann, H Iyer, A K Krauth, M-T Pickl, W F Marian, B Panzer-Grümayer, R Sillaber, C Maeda, H Zielinski, C Valent, P Producer: 20091214 In: Current cancer drug targets vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)